PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
7.01%
Growth of 7.01% while 3141.T shows flat revenue. Bruce Berkowitz would examine growth quality advantage.
8.23%
Cost growth of 8.23% while 3141.T maintains flat costs. Bruce Berkowitz would investigate efficiency gap.
2.37%
Growth of 2.37% while 3141.T shows flat gross profit. Bruce Berkowitz would examine quality advantage.
-4.34%
Margin decline while 3141.T shows 0.00% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-29.92%
Other expenses reduction while 3141.T shows 0.00% growth. Joel Greenblatt would examine efficiency.
2.35%
Operating expenses change of 2.35% while 3141.T maintains costs. Bruce Berkowitz would investigate control.
7.13%
Total costs change of 7.13% while 3141.T maintains costs. Bruce Berkowitz would investigate control.
3.45%
Interest expense change of 3.45% while 3141.T maintains costs. Bruce Berkowitz would investigate control.
25.94%
D&A change of 25.94% while 3141.T maintains D&A. Bruce Berkowitz would investigate efficiency.
22.81%
EBITDA change of 22.81% while 3141.T is flat. Bruce Berkowitz would examine quality.
14.76%
Margin change of 14.76% while 3141.T is flat. Bruce Berkowitz would examine quality.
2.53%
Income change of 2.53% while 3141.T is flat. Bruce Berkowitz would examine quality.
-4.19%
Operating margin decline while 3141.T shows 0.00% growth. Joel Greenblatt would examine position.
-26.75%
Other expenses reduction while 3141.T shows 0.00% growth. Joel Greenblatt would examine advantage.
-2.63%
Pre-tax income decline while 3141.T shows 0.00% growth. Joel Greenblatt would examine position.
-9.01%
Pre-tax margin decline while 3141.T shows 0.00% growth. Joel Greenblatt would examine position.
-2.33%
Tax expense reduction while 3141.T shows 0.00% growth. Joel Greenblatt would examine advantage.
-2.89%
Net income decline while 3141.T shows 0.00% growth. Joel Greenblatt would examine position.
-9.25%
Net margin decline while 3141.T shows 0.00% growth. Joel Greenblatt would examine position.
-2.89%
EPS decline while 3141.T shows 0.00% growth. Joel Greenblatt would examine position.
-2.89%
Diluted EPS decline while 3141.T shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.